[ad_1] Let’s talk about biotech. These stocks present a unique set of attractions for investors, especially investors willing to shoulder…
Read More »biotech
[ad_1] Intrinsic Medicine CEO Alex Martinez. (Intrinsic Photo) A deal to take Seattle biotech company Intrinsic Medicine public via a…
Read More »
[ad_1] Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and…
Read More »
[ad_1] IBD’s Income Investor column highlights top dividend stocks. With a long track record of dividend increases, AbbVie (ABBV) is…
Read More »
[ad_1] The Food and Drug Administration said Monday it will perform a speedy review of Sarepta Therapeutics‘ (SRPT) muscular dystrophy…
Read More »
[ad_1] Seattle-based Bonum Therapeutics designs therapies that can be administered systemically for targeted activation in the body. (Good Therapeutics Graphic)…
Read More »[ad_1] In a new step for Crispr, scientists have used the gene-editing tool to make personalized modifications to cancer patients’…
Read More »[ad_1] Sometimes, people in my life do something they think is kind: They look at me, smile beatifically, and say,…
Read More »[ad_1] Comparing those genomes to those of people without schizophrenia has allowed investigators to uncover multiple genes that have a…
Read More »[ad_1] The Crispr components can’t naturally get into cells on their own, so Intellia uses a delivery system called lipid…
Read More »